Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
01 Fevereiro 2024 - 6:05PM
Business Wire
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the
Company will provide a corporate update and report financial
results for the fourth quarter ended December 31, 2023, on February
22, 2024. The Company will host a conference call at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time on February 22, 2024.
The corporate update and financial results will be provided via
a press release after market close and will be accessible under
Press Releases in the Investors section of the Vir website at
www.vir.bio. Participants may access the conference call via
webcast on the Events & Presentations page of Vir’s website at
https://investors.vir.bio/events-presentations. A recorded version
of the call will be available on the website approximately two
hours after the completion of the event and will be archived there
for 30 days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is an immunology company focused on
combining cutting-edge technologies to treat and prevent infectious
diseases and other serious conditions. Vir has assembled two
technology platforms that are designed to stimulate and enhance the
immune system by exploiting critical observations of natural immune
processes. Its current clinical development pipeline consists of
product candidates targeting hepatitis delta and hepatitis B
viruses and human immunodeficiency virus. Vir has several
preclinical candidates in its pipeline, including those targeting
influenza A and B, COVID-19, RSV/MPV and HPV. Vir routinely posts
information that may be important to investors on its website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240208205237/en/
Media Carly Scaduto Senior Director, Media Relations
cscaduto@vir.bio +1 314-368-5189
Investors Sasha Damouni Ellis Executive Vice President,
Chief Corporate Affairs Officer sdamouni@vir.bio
Vir Biotechnology (NASDAQ:VIR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vir Biotechnology (NASDAQ:VIR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024